Ranbaxy launches acne drug in US

Mon Nov 26, 2012 1:44pm IST

Related Topics

Stocks

   

REUTERS - Ranbaxy Laboratories Ltd (RANB.NS), India's top drugmaker by sales, said it has launched Absorica, a drug used to treat recalcitrant acne, in the United States.

The drug is in-licensed from Cipher Pharmaceuticals Inc (DND.TO), said Ranbaxy, controlled by Japan's Daiichi Sankyo Co (4568.T), on Monday. (Reporting by Kaustubh Kulkarni in Mumbai)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

Jaitley's Health

Jaitley's Health

Finance minister back in hospital for check-up.  Full Article 

Modi's U.S. Visit

Modi's U.S. Visit

Modi to observe strict fast during maiden trip to U.S.  Full Article 

Mangalyaan

Mangalyaan

India's Mars mission a step closer to success with engine test  Full Article 

Shortage of Coal

Shortage of Coal

Coal import rush leads to port congestion  Full Article 

Alibaba IPO

Alibaba IPO

IPO ranks as world's biggest after additional shares sold   Full Article 

Bumper Sales

Bumper Sales

Apple sells more than 10 mln new iPhones in first three days  Full Article 

Asian Games 2014

Asian Games 2014

Full coverage of the 17th Asian Games as Incheon.  Full Coverage 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage